Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06738199 · ClinicalTrials.gov registry record · NA
Glycoprotein Matrix-Bound Iron Improves Iron Absorption
A NA study of Evaluation of Bioavailability of Supplemental Forms of Iron, sponsored by University of Mary Hardin-Baylor.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT06738199: Completed NA study of Evaluation of Bioavailability of Supplemental Forms of Iron, sponsored by University of Mary Hardin-Baylor.
NCT06738199 is a NA study of Evaluation of Bioavailability of Supplemental Forms of Iron that has completed, run by University of Mary Hardin-Baylor. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06738199, a NA study of Evaluation of Bioavailability of Supplemental Forms of Iron, has completed, sponsored by University of Mary Hardin-Baylor.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
A double-blind, randomized crossover study was conducted that evaluated absorption kinetics of 3 forms of dietary supplement iron by measuring iron levels in the blood after acute ingestion.
Primary Outcome
Blood levels were assessed to determine if absorption rates were different between the 3 arms (forms of iron). Blood samples were taken at 30-, 60-, 90-, 120-, 180-, 240-, 300-, 360-, 420-, and 480-minutes post-ingestion.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT dietary iron supplementation
Study Locations (1)
Texas
- Human Performance Lab - Belton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2024-04-22 |
| Phase | NA |
What the finished NCT06738199 record still lists
NCT06738199 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Evaluation of Bioavailability of Supplemental Forms of Iron appearing as the primary indexed condition, and to 1 intervention - of which dietary iron supplementation is the first listed.
NCT06738199 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06738199 about?
NCT06738199 is a clinical study titled "Glycoprotein Matrix-Bound Iron Improves Iron Absorption". A double-blind, randomized crossover study was conducted that evaluated absorption kinetics of 3 forms of dietary supplement iron by measuring iron levels in the blood after acute ingestion.
What is the current status of trial NCT06738199?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2024-02-01. Estimated completion is 2024-04-22.
What conditions does trial NCT06738199 study?
This clinical trial studies the following conditions: Evaluation of Bioavailability of Supplemental Forms of Iron.
What interventions are being tested in trial NCT06738199?
The interventions under investigation include: dietary iron supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06738199?
This trial is sponsored by University of Mary Hardin-Baylor, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06738199 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06738199's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI